FDA to remove ingredient from cold medicines after data shows it does not work
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines after studies showed it does not work.
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its job at "unstuffing" when taken by mouth.
FDA wants to pull decongestant found in many cold, allergy medicines
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here’s why.
FDA Claims Ingredients In Cold Medicines Is Ineffective
FDA Claims Ingredients In Cold Medicines Is Ineffective
FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You
The FDA has proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold medications.Last year, an FDA advisory committee concluded that the oral version of the medication is not effective at treating nasal congestion.
FDA wants to ban useless oronasal phenylephrine meds
Oral phenylephrine is sold as a nasal decongestant. It doesn't work very well, and the U.S. Food and Drug administration wants it removed from over-the-counter medications. The agency conducted a comprehensive review of all available data on the safety and efficacy of oral phenylephrine,
Yahoo Finance23m
Autolus secures FDA approval for CAR-T cell therapy use in ALL
Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for Aucatzyl (obecaktagene autoleucel), its ...
From AI to Musk’s brain chips, the FDA’s device unit faces rapid change
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
pharmaphorum18h
Unicycive eyes June FDA verdict for hyperphosphataemia drug
The FDA has started a review of Unicycive Therapeutics' drug for hyperphosphataemia in patients with chronic kidney disease ...
BioPharma Dive1h
FDA approves new CAR-T competitor to Gilead’s Tecartus
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
New York Sun2h
FDA Forces Costco To Recall 80,000 Pounds of Butter Because Packaging Did Not Say It ‘Contains Milk’
Costco is being forced to recall 80,000 pounds of butter in Texas because the packaging does not state it includes the base ...
Atlanta Journal-Constitution4h
FDA proposes pulling decongestants from shelves over one ingredient
For some products, it is the only ingredient, the FDA said in a news release issued Thursday. Others contain oral phenylephrine and acetaminophen, dextromethorphan or another active ingredient.
BioPharma Dive1h
FDA lifts pause on Novavax flu vaccine trials
The agency authorized Novavax to start a Phase 3 trial of its combination shot after the company “satisfactorily” addressed ...
Yahoo10h
FDA to Finally Ban Controversial Ingredient in Popular Decongestants
The US Food and Drug Administration (FDA) has now proposed an order to remove oral phenylephrine from every single cold, ...
RFK Jr. Gloats About Plan to Gut FDA Under Trump
Donald Trump associate and noted health nut Robert F. Kennedy Jr. still has federal health regulators in his crosshairs. On ...
Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot
The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported on Monday (NASDAQ:MNDY ...